USENSE relies on the multiplexed electrochemical quantitation of a unique combination of three UTI‐relevant biomarkers, Prostaglandin E2 (PGE2), Interleukin‐8 (IL‐8), and Lipopolysaccharide (LPS), in unfiltered human urine. The gene discussed is CXCL8; the disease is bacterial urinary tract infection.